Matches in SemOpenAlex for { <https://semopenalex.org/work/W1569173737> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W1569173737 abstract "INTRODUCTION: Performance status (PS) 2 patients with non-small cell lung cancer (NSCLC) experience more toxicity, lower response rates, and shorter survival times than healthier patients treated with standard chemotherapy. Paclitaxel poliglumex (PPX), a macromolecule drug conjugate of paclitaxel and polyglutamic acid, reduces systemic exposure to peak concentrations of free paclitaxel and may lead to increased concentrations in tumors due to enhanced vascular permeability. METHODS: Chemotherapy-naive PS 2 patients with advanced NSCLC were randomized to receive carboplatin (area under the curve = 6) and either PPX (210 mg/m/10 min without routine steroid premedication) or paclitaxel (225 mg/m/3 h with standard premedication) every 3 weeks. The primary end point was overall survival. RESULTS: A total of 400 patients were enrolled. Alopecia, arthralgias/myalgias, and cardiac events were significantly less frequent with PPX/carboplatin, whereas grade ≥3 neutropenia and grade 3 neuropathy showed a trend of worsening. There was no significant difference in the incidence of hypersensitivity reactions despite the absence of routine premedication in the PPX arm. Overall survival was similar between treatment arms (hazard ratio, 0.97; log rank p = 0.769). Median and 1-year survival rates were 7.9 months and 31%, for PPX versus 8 months and 31% for paclitaxel. Disease control rates were 64% and 69% for PPX and paclitaxel, respectively. Time to progression was similar: 3.9 months for PPX/carboplatin versus 4.6 months for paclitaxel/carboplatin (p = 0.210). CONCLUSION: PPX/carboplatin failed to provide superior survival compared with paclitaxel/carboplatin in the first-line treatment of PS 2 patients with NSCLC, but the results with respect to progression-free survival and overall survival were comparable and the PPX regimen was more convenient. © 2008International Association for the Study of Lung Cancer." @default.
- W1569173737 created "2016-06-24" @default.
- W1569173737 creator A5001591653 @default.
- W1569173737 creator A5002341560 @default.
- W1569173737 creator A5003218467 @default.
- W1569173737 creator A5005875420 @default.
- W1569173737 creator A5016497775 @default.
- W1569173737 creator A5021258719 @default.
- W1569173737 creator A5033519199 @default.
- W1569173737 creator A5035507692 @default.
- W1569173737 creator A5045366442 @default.
- W1569173737 creator A5050758074 @default.
- W1569173737 creator A5061972659 @default.
- W1569173737 creator A5077459059 @default.
- W1569173737 creator A5078629724 @default.
- W1569173737 creator A5087769609 @default.
- W1569173737 creator A5090256464 @default.
- W1569173737 date "2008-01-01" @default.
- W1569173737 modified "2023-09-26" @default.
- W1569173737 title "Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer" @default.
- W1569173737 hasPublicationYear "2008" @default.
- W1569173737 type Work @default.
- W1569173737 sameAs 1569173737 @default.
- W1569173737 citedByCount "0" @default.
- W1569173737 crossrefType "journal-article" @default.
- W1569173737 hasAuthorship W1569173737A5001591653 @default.
- W1569173737 hasAuthorship W1569173737A5002341560 @default.
- W1569173737 hasAuthorship W1569173737A5003218467 @default.
- W1569173737 hasAuthorship W1569173737A5005875420 @default.
- W1569173737 hasAuthorship W1569173737A5016497775 @default.
- W1569173737 hasAuthorship W1569173737A5021258719 @default.
- W1569173737 hasAuthorship W1569173737A5033519199 @default.
- W1569173737 hasAuthorship W1569173737A5035507692 @default.
- W1569173737 hasAuthorship W1569173737A5045366442 @default.
- W1569173737 hasAuthorship W1569173737A5050758074 @default.
- W1569173737 hasAuthorship W1569173737A5061972659 @default.
- W1569173737 hasAuthorship W1569173737A5077459059 @default.
- W1569173737 hasAuthorship W1569173737A5078629724 @default.
- W1569173737 hasAuthorship W1569173737A5087769609 @default.
- W1569173737 hasAuthorship W1569173737A5090256464 @default.
- W1569173737 hasConcept C126322002 @default.
- W1569173737 hasConcept C126894567 @default.
- W1569173737 hasConcept C141071460 @default.
- W1569173737 hasConcept C143998085 @default.
- W1569173737 hasConcept C207103383 @default.
- W1569173737 hasConcept C2776256026 @default.
- W1569173737 hasConcept C2776694085 @default.
- W1569173737 hasConcept C2777292972 @default.
- W1569173737 hasConcept C2778239845 @default.
- W1569173737 hasConcept C2778300832 @default.
- W1569173737 hasConcept C2781451048 @default.
- W1569173737 hasConcept C44249647 @default.
- W1569173737 hasConcept C71924100 @default.
- W1569173737 hasConcept C90924648 @default.
- W1569173737 hasConcept C98274493 @default.
- W1569173737 hasConceptScore W1569173737C126322002 @default.
- W1569173737 hasConceptScore W1569173737C126894567 @default.
- W1569173737 hasConceptScore W1569173737C141071460 @default.
- W1569173737 hasConceptScore W1569173737C143998085 @default.
- W1569173737 hasConceptScore W1569173737C207103383 @default.
- W1569173737 hasConceptScore W1569173737C2776256026 @default.
- W1569173737 hasConceptScore W1569173737C2776694085 @default.
- W1569173737 hasConceptScore W1569173737C2777292972 @default.
- W1569173737 hasConceptScore W1569173737C2778239845 @default.
- W1569173737 hasConceptScore W1569173737C2778300832 @default.
- W1569173737 hasConceptScore W1569173737C2781451048 @default.
- W1569173737 hasConceptScore W1569173737C44249647 @default.
- W1569173737 hasConceptScore W1569173737C71924100 @default.
- W1569173737 hasConceptScore W1569173737C90924648 @default.
- W1569173737 hasConceptScore W1569173737C98274493 @default.
- W1569173737 hasOpenAccess W1569173737 @default.
- W1569173737 hasRelatedWork W1528415765 @default.
- W1569173737 hasRelatedWork W1571466982 @default.
- W1569173737 hasRelatedWork W1863199995 @default.
- W1569173737 hasRelatedWork W1969431083 @default.
- W1569173737 hasRelatedWork W1981307812 @default.
- W1569173737 hasRelatedWork W2025626703 @default.
- W1569173737 hasRelatedWork W2067551135 @default.
- W1569173737 hasRelatedWork W2111166863 @default.
- W1569173737 hasRelatedWork W2113457173 @default.
- W1569173737 hasRelatedWork W2123893788 @default.
- W1569173737 hasRelatedWork W2128941584 @default.
- W1569173737 hasRelatedWork W2138035969 @default.
- W1569173737 hasRelatedWork W2163186938 @default.
- W1569173737 hasRelatedWork W2349790989 @default.
- W1569173737 hasRelatedWork W2360704785 @default.
- W1569173737 hasRelatedWork W2375370454 @default.
- W1569173737 hasRelatedWork W2385754571 @default.
- W1569173737 hasRelatedWork W2403820072 @default.
- W1569173737 hasRelatedWork W2419086312 @default.
- W1569173737 hasRelatedWork W3104220902 @default.
- W1569173737 isParatext "false" @default.
- W1569173737 isRetracted "false" @default.
- W1569173737 magId "1569173737" @default.
- W1569173737 workType "article" @default.